RegeneRx Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4 (Tß4), for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for dermal wounds and reduction of scar tissue.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone301-208-9191
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$70,000.00
Profitability
Miscellaneous
Employees3
Next Earnings Date7/2/2019 (Estimated)
OptionableNot Optionable
RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) Frequently Asked Questions
What is RegeneRx Biopharmaceuticals' stock symbol?
RegeneRx Biopharmaceuticals trades on the OTCMKTS under the ticker symbol "RGRX."
When is RegeneRx Biopharmaceuticals' next earnings date?
Has RegeneRx Biopharmaceuticals been receiving favorable news coverage?
News stories about RGRX stock have trended positive on Wednesday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. RegeneRx Biopharmaceuticals earned a media sentiment score of 2.3 on InfoTrie's scale. They also assigned press coverage about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for RegeneRx Biopharmaceuticals.
Who are some of RegeneRx Biopharmaceuticals' key competitors?
Some companies that are related to RegeneRx Biopharmaceuticals include Processa Pharmaceuticals (PCSA), Savara (SVRA), Correvio Pharma (CORV), Catalyst Biosciences (CBIO), Aridis Pharmaceuticals (ARDS), Trevena (TRVN), Catabasis Pharmaceuticals (CATB), Selecta Biosciences (SELB), Iterum Therapeutics (ITRM), Bellicum Pharmaceuticals (BLCM), Generex Biotechnology (GNBT), Alpine Immune Sciences (ALPN), Acasti Pharma (ACST), Entasis Therapeutics (ETTX) and Inflarx (IFRX).
What other stocks do shareholders of RegeneRx Biopharmaceuticals own?
Who are RegeneRx Biopharmaceuticals' key executives?
RegeneRx Biopharmaceuticals' management team includes the folowing people:
- Dr. Allan L. Goldstein, Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board (Age 81)
- Mr. J. J. Finkelstein, Pres, CEO & Director (Age 67)
- Mr. Dane R. Saglio, Chief Financial Officer (Age 61)
- Dr. Nabila A. Turjman Ph.D., Exec. Director of Regulatory Affairs
How do I buy shares of RegeneRx Biopharmaceuticals?
Shares of RGRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is RegeneRx Biopharmaceuticals' stock price today?
One share of RGRX stock can currently be purchased for approximately $0.1850.
How big of a company is RegeneRx Biopharmaceuticals?
What is RegeneRx Biopharmaceuticals' official website?
How can I contact RegeneRx Biopharmaceuticals?
RegeneRx Biopharmaceuticals' mailing address is 15245 SHADY GROVE ROAD SUITE 470, ROCKVILLE MD, 20850. The biopharmaceutical company can be reached via phone at 301-208-9191 or via email at [email protected]
MarketBeat Community Rating for RegeneRx Biopharmaceuticals (OTCMKTS RGRX)
MarketBeat's community ratings are surveys of what our community members think about RegeneRx Biopharmaceuticals and other stocks. Vote "Outperform" if you believe RGRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RGRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
